InvestorsObserver
×
News Home

Adamis Pharmaceuticals Corp (ADMP) is down 1.47% Tuesday In Premarket Trading

Tuesday, August 08, 2023 09:04 AM | InvestorsObserver Analysts

Mentioned in this article

Adamis Pharmaceuticals Corp (ADMP) is down 1.47% Tuesday In Premarket Trading

Adamis Pharmaceuticals Corp (ADMP) is lower by Tuesday morning, with the stock falling -1.47% in pre-market trading to 1.34. ADMP's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 141 out of 146 industries, Adamis Pharmaceuticals Corp ranks higher than 1% of stocks. Adamis Pharmaceuticals Corp has fallen 36.74% over the past month, closing at $2.20 on July 11. During this period of time, the stock fell as low as $1.33 and as high as $8.28.

Overall Score - 6
ADMP has an Overall Score of 6. Find out what this means to you and get the rest of the rankings on ADMP!
Adamis Pharmaceuticals Corp has a Long-Term Technical rank of 19. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 81% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 135 by this metric, ADMP ranks better than 135% of stocks.

Important Dates for Investors in ADMP:

-Adamis Pharmaceuticals Corp is set to release earnings on 8/9/2023. Over the last 12 months, the company has reported EPS of $-0.05. -We do not have a set dividend date for Adamis Pharmaceuticals Corp at this time. Click Here To Get The Full Report on Adamis Pharmaceuticals Corp (ADMP)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App